Wengang Li

发表

Consensus on the secondary prevention of primary liver cancer

Peng Hu, C. Xie, J. Niu, 2021, Hepatology International.

CyberKnife Stereotactic Body Radiation Therapy as an Effective Treatment for Hepatocellular Carcinoma Patients With Decompensated Cirrhosis

Wengang Li, Yu-Ze Fan, Jing Sun, 2020, Frontiers in Oncology.

The effects of stereotactic body radiotherapy on peripheral natural killer and CD3+CD56+ NKT-like cells in patients with hepatocellular carcinoma.

Wengang Li, T. Li, Jing Sun, 2021, Hepatobiliary & pancreatic diseases international : HBPD INT.

Prognosis and Risk Factors of Recurrence in HBV-Related Small Hepatocellular Carcinoma After Stereotactic Body Radiation Therapy

Xiaoyuan Xu, Wengang Li, Ning Tan, 2022, Frontiers in Oncology.

The Chinese Society of Hepatology position statement on the redefinition of fatty liver disease.

Ming Yan, Xinxin Zhang, Shumei Lin, 2021, Journal of hepatology.

CyberKnife Stereotactic Body Radiation Therapy for Small Hepatocellular Carcinoma Patients with Decompensated Cirrhosis: protocol of study

Wengang Li, Jing Sun, Dan Zhang, 2020 .

Chinese guidelines on the management of ascites and its related complications in cirrhosis

Lai Wei, H. Zhuang, Wengang Li, 2019, Hepatology International.

Chinese guidelines on the management of liver cirrhosis (abbreviated version)

Lai Wei, H. Zhuang, Wengang Li, 2020, World journal of gastroenterology.

Stereotactic body radiotherapy versus hepatic resection for hepatocellular carcinoma (≤ 5 cm): a propensity score analysis

Wengang Li, Yu-Ze Fan, Jing Sun, 2020, Hepatology International.

Biologically effective dose (BED) escalation of stereotactic body radiotherapy (SBRT) for hepatocellular carcinoma patients (≤5 cm) with CyberKnife: protocol of study

Wengang Li, Jing Sun, A. Zhang, 2020, Radiation Oncology.

Biologically effective dose (BED) of stereotactic body radiation therapy (SBRT) was an important factor of therapeutic efficacy in patients with hepatocellular carcinoma (≤5 cm)

Wengang Li, Jing Sun, A. Zhang, 2019, BMC Cancer.

Clinical Values and Markers of Radiation-Induced Liver Disease for Hepatocellular Carcinoma With Portal Vein Tumor Thrombus Treated With Stereotactic Body Radiotherapy

J. Jia, Wengang Li, Jing Sun, 2021, Frontiers in Oncology.

Biologically effective dose (BED) of stereotactic body radiation therapy (SBRT) was an important factor of therapeutic efficacy in patients with hepatocellular carcinoma (≤5 cm)

Wengang Li, Jing Sun, A. Zhang, 2019, BMC Cancer.

Chinese guidelines on management of hepatic encephalopathy in cirrhosis

Lai Wei, H. Zhuang, Wengang Li, 2019, World journal of gastroenterology.

Hepatic Resection Versus Stereotactic Body Radiation Therapy Plus Transhepatic Arterial Chemoembolization for Large Hepatocellular Carcinoma: A Propensity Score Analysis

Wengang Li, P. Han, Hong-bo Wang, 2021, Journal of clinical and translational hepatology.

Lenvatinib with or without stereotactic body radiotherapy for hepatocellular carcinoma with portal vein tumor thrombosis: a retrospective study

Zhe Xu, Wengang Li, Jing Sun, 2023, Radiation Oncology.

Comparison of stereotactic body radiotherapy with and without lenvatinib for advanced hepatocellular carcinoma: a propensity score analysis

Wengang Li, Jing Sun, A. Zhang, 2023, Journal of Cancer Research and Clinical Oncology.

Biologically effective dose (BED) escalation of stereotactic body radiotherapy (SBRT) for hepatocellular carcinoma patients (≤5 cm) with CyberKnife: protocol of study

Wengang Li, Jing Sun, A. Zhang, 2020, Radiation oncology.